Henry Schein (NSDQ:HSIC) said today it is on track to complete the spinout of its animal health business, Covetrus, which is slated to close today with shares in the company beginning trading tomorrow on the Nasdaq Global Select Market. The Melville, N.Y.-based company said that its common stock won approval for listing on the Nasdaq Global […]
Business/Financial News
Wall Street Beat | Earnings Reports | Funding Roundup | Mergers & Acquisitions | Initial Public Offerings | Legal News
Swedish patient receives ‘dexterous, sentient’ prosthetic hand
A Swedish woman with a hand amputation has become the first recipient of an osseo-neuromuscular implant to control a dexterous hand prosthesis, according to Chalmers University of Technology in Gothenburg, Sweden. Surgeons placed titanium implants in the two forearm bones (radius and ulna), and extended electrodes to nerves and muscle to extract signals to control a […]
3M names CEO Roman as board chair | Personnel Moves – February 7, 2019
3M (NYSE:MMM) said yesterday that its board of directors nominated CEO Mike Roman as its new chairperson, with current exec chair Inge Thulin announcing their intention to retire. The move is slated to take effect following the St. Paul, Minn.-based company’s annual meeting of shareholders on May 14. “Under Inge’s leadership, 3M evolved into a more […]
UPDATED: Cook Medical to pay $3m in damages in IVC bellwether
Updated to include a response from Cook Medical A federal jury in Indiana last week awarded $3 million in damages to a plaintiff in a bellwether case against Cook Medical over allegedly defective designs in the company’s Celect inferior vena cava filters. The plaintiff, Tonya Brand, sued Cook in 2014 alleging that the Celect IVC filter […]
Pulmatrix wins FDA nod for PhII trial of inhaled anti-fungal therapy
Pulmatrix (NSDQ:PULM) said today that the FDA approved a Phase II trial of the company’s inhaled formulation of the anti-fungal drug itraconazole for the treatment of allergic bronchopulmonary aspergillosis in people with asthma. The Lexington, Mass.-based company plans to kick off the trial in the first half of 2019, with top-line data expected in the second […]
Bigfoot Biomedical, Owen Mumford ink deal for pen needles
Bigfoot Biomedical said today that it inked a commercial supply deal to include Owen Mumford‘s Pentips line of pen needles with Bigfoot’s injection system subscription bundles. Milpitas, Calif.-based Bigfoot is working on monthly subscription packages for people with insulin-requiring diabetes. The company said it selected Owen Mumford’s pen needle because of the needle’s compatibility with all disposable […]
Inspire Medical wins coverage from five more BCBS plans
Inspire Medical Systems (NYSE:INSP) (“Inspire”) said it has secured positive coverage policies for its Inspire neurostimulation therapy, intended to treat obstructive sleep apnea, from an additional five Blue Cross Blue Shield Association healthcare plans. These plans include Blue Cross Blue Shield of Mississippi, BCBS Regence, Premera Blue Cross, BCBS of Kansas, and BCBS of Massachusetts. […]
Cardinal Health shares rise on FY2019 Q2 earnings beat
Shares in Cardinal Health (NYSE:CAH) are rising in early morning trading after the medical device maker posted second quarter fiscal year 2019 earnings that handily topped Wall Street analyst’s expectations. The Dublin, Ohio-based company posted profits of $280 million, or 93¢ per share, on sales of $37.7 billion for the three months ended December 31, seeing […]
Trice Medical to acquire SegWay Ortho
Trice Medical said today that it inked a deal to acquire SegWay Orthopaedics for an undisclosed amount. SegWay Ortho produces solutions for minimally invasive orthopedic procedures, including its flagship Endoscopic Carpal Tunnel Release system, a device intended to support minimally invasive carpal tunnel surgeries, Malvern, Penn.-based Trice Medical said. The company’s SegWay platform is also used […]
Smith & Nephew shares up on Q4, FY2018 results
Shares in Smith & Nephew (NYSE:SNN) are rising today after the medical device maker posted fourth quarter and full year 2018 earnings, and guidance for the coming year, mostly in line with analyst’s expectations. For its fourth quarter, the British medtech company reported sales growth of approximately 1.3% to $1.29 billion, just behind analyst’s expectations of […]
Avedro sets $75m IPO terms
Avedro has set the terms for its initial public offering, looking to raise between $70 million and $80 million in total. The Waltham, Mass.-based ophthalmic device company said it plans to float 5 million shares of its common stock at between $14 and $16 per share. The company said it also plans to grant a 30-day […]